ketanserin has been researched along with morphine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Kamei, J; Kasuya, Y; Tanihara, H | 1 |
| Bieger, D; Triggle, C | 1 |
| Mana, MJ; Paul, D; Pfaus, JG; Pinel, JP | 1 |
| Johnson, JH; Lenahan, SE; Seibel, HR | 1 |
| Anton, F; Ebersberger, A; Tölle, TR; Zieglgänsberger, W | 1 |
| Goshadrou, F; Pourgholami, MH | 1 |
| Bjijou, Y; Cador, M; Le Moal, M; Stinus, L | 1 |
| Ottani, A; Pini, LA; Sandrini, M; Vitale, G | 1 |
| Duman, EN; Erciyes, N; Kadioglu, M; Kalyoncu, NI; Kesim, M; Yaris, E | 1 |
| Dogrul, A; Seyrek, M | 1 |
| France, CP; Javors, MA; Koek, W; Li, JX; Rice, KC; Unzeitig, A | 1 |
| Climent, L; Horga, A; Horga, JF; Peiró, AM; Zapater, P | 1 |
| Arslan, R; Bektas, N; Ozturk, Y | 1 |
| Back, SK; Han, RT; Kim, HJ; Lee, H; Lee, J; Lee, SB; Na, HS | 1 |
| Abbasi-Maleki, S; Mesbahzadeh, B; Moradi-Kor, N | 1 |
20 other study(ies) available for ketanserin and morphine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Antitussive Agents; Cisterna Magna; Cough; Injections; Ketanserin; Male; Methysergide; Morphine; Naloxone; Naltrexone; Pyrrolidines; Rats; Rats, Inbred Strains; Reflex | 1990 |
Pharmacological properties of mechanical responses of the rat oesophageal muscularis mucosae to vagal and field stimulation.
Topics: Animals; Dioxolanes; Electric Stimulation; Esophagus; Hexamethonium Compounds; In Vitro Techniques; Ketanserin; Male; Morphine; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Naloxone; Piperidines; Rats; Rats, Inbred Strains; Scopolamine Derivatives; Serotonin; Tetrodotoxin; Tubocurarine; Vagus Nerve | 1985 |
Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin.
Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Ketamine; Ketanserin; Male; Morphine; Piperidines; Rats; Reaction Time; Receptors, Serotonin; Serotonin Antagonists | 1988 |
Opiate-serotonin synergism stimulating luteinizing hormone release in estrogen-progesterone-primed ovariectomized rats: mediation by serotonin2 receptors.
Topics: Animals; Estradiol; Female; Ketanserin; Luteinizing Hormone; Methysergide; Morphine; Ovariectomy; Progesterone; Quinolines; Quipazine; Rats; Receptors, Serotonin; Serotonin | 1987 |
Morphine, 5-HT2 and 5-HT3 receptor antagonists reduce c-fos expression in the trigeminal nuclear complex following noxious chemical stimulation of the rat nasal mucosa.
Topics: Animals; Gene Expression Regulation; Genes, fos; Indoles; Ketanserin; Male; Morphine; Mustard Plant; Nasal Mucosa; Plant Extracts; Plant Oils; Plants, Medicinal; Rats; Rats, Wistar; Serotonin Antagonists; Stimulation, Chemical; Trigeminal Nuclei; Tropisetron | 1995 |
Evidence for serotonergic system involvement in the effect of morphine on gastrointestinal motility in the rat.
Topics: 5,7-Dihydroxytryptamine; Animals; Central Nervous System; Charcoal; Depression, Chemical; Dose-Response Relationship, Drug; Fenclonine; Fenfluramine; Gastrointestinal Motility; Ketanserin; Male; Morphine; Naloxone; Rats; Serotonin | 1995 |
Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine.
Topics: Animals; Autoreceptors; Benzazepines; Dextroamphetamine; Ketanserin; Male; Morphine; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-B; Receptors, Serotonin; Ventral Tegmental Area | 1996 |
Naloxone-reversible antinociception by paracetamol in the rat.
Topics: Acetaminophen; Animals; Cerebral Cortex; Formaldehyde; Hot Temperature; Ketanserin; Kinetics; Male; Morphine; Motor Activity; Naloxone; Pain; Pons; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Stereotyped Behavior | 1997 |
The different roles of 5-HT(2) and 5-HT(3) receptors on antinociceptive effect of paroxetine in chemical stimuli in mice.
Topics: Abdominal Pain; Acetic Acid; Analgesia; Analgesics; Animals; Dose-Response Relationship, Drug; Drug Synergism; Female; Injections, Intraperitoneal; Ketanserin; Male; Mice; Mice, Inbred BALB C; Morphine; Naloxone; Ondansetron; Pain Measurement; Paroxetine; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3 | 2005 |
Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Injections, Spinal; Ketanserin; Male; Metergoline; Mice; Mice, Inbred BALB C; Morphine; Pain; Pain Measurement; Phenols; Piperazines; Pyridines; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Serotonin Antagonists; Spinal Cord; Sulfonamides | 2006 |
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Animals; Conditioning, Operant; Discrimination, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Ketamine; Ketanserin; Male; Morphine; Phencyclidine; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Ketanserin potentiates morphine-induced antinociception mediated by kappa-receptor activation.
Topics: Adrenergic alpha-1 Receptor Antagonists; Analgesics; Animals; Dose-Response Relationship, Drug; Drug Synergism; Ketanserin; Male; Mice; Mice, Inbred Strains; Morphine; Naltrexone; Pain; Pain Measurement; Pain Threshold; Prazosin; Pyrrolidines; Receptors, Adrenergic, alpha-1; Receptors, Opioid, kappa; Receptors, Serotonin, 5-HT2; Serotonin Antagonists | 2011 |
Zonisamide: Antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.
Topics: Animals; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Isoxazoles; Ketanserin; Male; Morphine; Ondansetron; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin, 5-HT3; Streptozocin; Zonisamide | 2014 |
Brief Isolation Changes Nociceptive Behaviors and Compromises Drug Tests in Mice.
Topics: Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Drug Evaluation, Preclinical; Feces; Hot Temperature; Ketanserin; Male; Mice; Mice, Inbred C57BL; Morphine; Naloxone; Narcotic Antagonists; Nociceptive Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Serotonin Antagonists; Social Isolation; Vasotocin | 2016 |
Zinc enhances the expression of morphine-induced conditioned place preference through dopaminergic and serotonergic systems.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Ketanserin; Male; Morphine; Ondansetron; Piperazines; Rats; Rats, Wistar; Reward; Serotonin Antagonists; Sulpiride; Zinc | 2019 |